PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - Enzalutamide

Clinical trial NCT05539300 · UNKNOWN

Trial details

NCT number: NCT05539300
Sponsor: UMC Utrecht
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2023-03-01
Primary completion: 2026-01-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.